Abstract Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and
thromboembolic events, owing to excessive inflammation, endothelial cell activation and …

The acute course of COVID-19 is variable and ranges from asymptomatic infection to
fulminant respiratory failure. Patients recovering from COVID-19 can have persistent …

Background: Numerous tools, including nutritional and inflammatory markers, have been
evaluated as the predictors of poor outcomes in COVID-19 patients. This study aims to verify …

Objectives To investigate whether COVID-19 patients with pulmonary embolism had higher
mortality and assess the utility of d-dimer in predicting acute pulmonary embolism. Patients …

Background The current COVID-19 pandemic from the human pathogenic virus SARS-CoV-
2 has resulted in a major health hazard globally. The morbidity and transmission modality of …

In acute coronavirus disease 19 (COVID‐19) patients, effective clinical risk stratification has
important implications on treatment and therapeutic resource distribution. This article …

Please see the Editorial Comment by Andetta Hunsaker discussing this article. Filling
defects identified in the pulmonary arterial tree are commonly presumed to represent an …

Elevated D-dimer plasma concentrations are common in hospitalized COVID-19 patients
and are often associated with a worse prognosis, but it is not yet clear whether this also …

The pathophysiology of coronavirus disease-2019 (COVID-19)-related acute respiratory
distress syndrome (ARDS) varies from other pneumonia-related ARDS. We evaluated …

Rationale Abnormal values of hypercoagulability biomarkers, such as D-dimer, have been
described in Coronavirus Disease 2019 (COVID-19), which has also been associated with …